Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Clinical Lymphoma|April 4, 2003
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosisDavid C Seldin, Elie B Choufani, Laura M Dember, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2010
Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathwayJianru Shi, Jian Guan, Bingbing Jiang, et al.
Toxicologic Pathology|November 3, 2005
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumorsNicolas Currier, Sandra E Solomon, Elizabeth G Demicco, et al.
Annals of Internal Medicine|January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year studyMartha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
Blood|May 28, 2017
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosisVaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, et al.
The Journal of Clinical Investigation|July 11, 2006
The A2B adenosine receptor protects against inflammation and excessive vascular adhesionDan Yang, Ying Zhang, Hao G Nguyen, et al.
Stem Cell Reports|November 29, 2013
Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosisAmy Leung, Shirley K Nah, Whitney Reid, et al.
Pageof 11